AI assistant
Cryoport, Inc. — Director's Dealing 2024
Nov 26, 2024
32876_dirs_2024-11-25_2d5d15d4-a172-4858-8bf7-bd0edaf580e4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2024-11-21
Reporting Person: SHELTON JERRELL (Director, President, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-21 | Common Stock | M | 59150 | $4.80 | Acquired | 781897 | Direct |
| 2024-11-21 | Common Stock | S | 50000 | $6.5055 | Disposed | 731897 | Direct |
| 2024-11-22 | Common Stock | M | 26862 | $4.80 | Acquired | 758759 | Direct |
| 2024-11-22 | Common Stock | S | 22817 | $6.4694 | Disposed | 735942 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-21 | Stock Option (right to buy) | $4.80 | M | 59150 | Disposed | 2024-12-18 | Common Stock (59150) | Direct |
| 2024-11-22 | Stock Option (right to buy) | $4.80 | M | 26862 | Disposed | 2024-12-18 | Common Stock (26862) | Direct |
Footnotes
F1: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.31 to $6.66, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.34 to $6.60, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015.